It is also interesting to note that expression of several SIN3A and SIN3B target genes in our data sets are consistent with the relapse-free survival identified for SIN3A and SIN3B for patients with triple negative breast cancer. This evidence concerns the gene SIN3B and triple-negative breast carcinoma.